Datamatics Global Services Limited (DATAMATICS) Latest Updates

Trading Window Closure for Q3 Results The company has officially closed its trading window for all directors and designated persons effective January 1, 2026. This closure is in anticipation of the upcoming Q3 FY26 financial results (for the quarter ended December 31, 2025). The window will remain shut until 48 hours after the results are declared. While a specific board meeting date has not been announced yet, historically, the company releases its Q3 results in late January or early February. Acquisition of TNQ Tech In a major move to bolster its digital content and AI segment, Datamatics recently completed the acquisition of a 100% stake in TNQ Tech Private Limited, a Chennai-based digital publishing technology firm. This acquisition adds approximately 2,500 employees to the group and significantly enhances Datamatics' suite of AI-enabled content technologies. TNQ Tech will operate as a step-down subsidiary, strengthening the company's presence in Europe and North America. Strategic Partnership with Well Pharmacy (UK) Datamatics has entered a significant partnership with Well Pharmacy, the UK's largest independent pharmacy chain. The collaboration focuses on modernizing medication record-keeping for over 70,000 patients in care homes. Datamatics is deploying its intelligent automation products—TruCap+ (for document processing) and TruBot (for robotic process automation)—to digitize the Medication Administration Record (MAR) process. AI-First Strategy and Product Evolution The company is aggressively pursuing an "AI-First" strategy, investing approximately ₹40–50 crore annually in AI and emerging technologies. This includes the recent launch of a new version of TruCap+, which features template-free document processing using pre-built AI/ML capabilities. Management has expressed confidence in doubling its FY24 revenues within the next two years, citing strong traction in GenAI-driven digital transformation projects.